9 research outputs found
Influence of Different Phase-Forming Parameters on the Phase Diagram of Several PEG–Salt Aqueous Two-Phase Systems
Different poly(ethylene glycol) (PEG)
+ potassium phosphate or
sodium citrate aqueous two-phase systems (ATPS) were investigated
at 23 °C, containing different PEG types (molecular weights 2000
g·mol<sup>–1</sup> to 8000 g·mol<sup>–1</sup>) and pH values (5 to 9). Furthermore, the effect of the added salt
NaCl (0 wt % to 8 wt %) on the PEG + potassium phosphate/sodium citrate
ATPS was studied at 23 °C. The experimental binodal data were
successfully correlated with the empirical nonlinear equation proposed
by Hu. The effects of increasing molecular weight of PEG, pH, NaCl,
and salt type on the obtained binodal curves were determined, resulting
in a binodal curve shift toward the origin. Thus, an expansion of
the two-phase region occurred by increasing molecular weight of the
PEG, pH, and NaCl and due to the Gibbs free energy of hydration of
ions of phosphate. Furthermore, the phase equilibrium compositions,
tie-line lengths, slopes of tie-lines, critical points, and effective
excluded volumes were obtained for all studied systems. Finally, the
experimental tie-line compositions were successfully correlated by
using the Othmer–Tobias and Bancroft equations, and linear
dependency was confirmed
Label-Free Optical Biosensors Based on Aptamer-Functionalized Porous Silicon Scaffolds
A proof-of-concept
for a label-free and reagentless optical biosensing
platform based on nanostructured porous silicon (PSi) and aptamers
is presented in this work. Aptamers are oligonucleotides (single-stranded
DNA or RNA) that can bind their targets with high affinity and specificity,
making them excellent recognition elements for biosensor design. Here
we describe the fabrication and characterization of aptamer-conjugated
PSi biosensors, where a previously characterized his-tag binding aptamer
(6H7) is used as model system. Exposure of the aptamer-functionalized
PSi to the target proteins as well as to complex fluids (i.e., bacteria
lysates containing target proteins) results in robust and well-defined
changes in the PSi optical interference spectrum, ascribed to specific
aptamer-protein binding events occurring within the nanoscale pores,
monitored in real time. The biosensors show exceptional stability
and can be easily regenerated by a short rinsing step for multiple
biosensing analyses. This proof-of-concept study demonstrates the
possibility of designing highly stable and specific label-free optical
PSi biosensors, employing aptamers as capture probes, holding immense
potential for application in detection of a broad range of targets,
in a simple yet reliable manner
Supplemental_Material_Austerjostetal.pdf – Supplemental material for Introducing a Virtual Assistant to the Lab: A Voice User Interface for the Intuitive Control of Laboratory Instruments
<p>Supplemental material, Supplemental_Material_Austerjostetal.pdf for Introducing a Virtual Assistant to the Lab: A Voice User Interface for the Intuitive Control of Laboratory Instruments by Jonas Austerjost, Marc Porr, Noah Riedel, Dominik Geier, Thomas Becker, Thomas Scheper, Daniel Marquard, Patrick Lindner and Sascha Beutel in SLAS Technology</p
Aqueous Synthesis of PEGylated Quantum Dots with Increased Colloidal Stability and Reduced Cytotoxicity
Ligands used on the surface of colloidal
nanoparticles (NPs) have
a significant impact on physiochemical properties of NPs and their
interaction in biological environments. In this study, we report a
one-pot aqueous synthesis of 3-mercaptopropionic acid (MPA)-functionalized
CdTe/CdS/ZnS quantum dots (Qdots) in the presence of thiol-terminated
methoxy polyethylene glycol (mPEG) molecules as a surface coordinating
ligand. The resulting mPEG–Qdots were characterized by using
ζ potential, FTIR, thermogravimetric (TG) analysis, and microscale
thermophoresis (MST) studies. We investigated the effect of mPEG molecules
and their grafting density on the Qdots photophysical properties,
colloidal stability, protein binding affinity, and in vitro cellular
toxicity. Moreover, cellular binding features of the resulting Qdots
were examined by using three-dimensional (3D) tumor-like spheroids,
and the results were discussed in detail. Promisingly, mPEG ligands
were found to increase colloidal stability of Qdots, reduce adsorption
of proteins to the Qdot surface, and mitigate Qdot-induced side effects
to a great extent. Flow cytometry and confocal microscopy studies
revealed that PEGylated Qdots exhibited distinctive cellular interactions
with respect to their mPEG grafting density. As a result, mPEG molecules
demonstrated a minimal effect on the ZnS shell deposition and the
Qdot fluorescence efficiency at a low mPEG density, whereas they showed
pronounced effect on Qdot colloidal stability, protein binding affinity,
cytotoxicity, and nonspecific binding at a higher mPEG grafting amount
Nanostructured Amphiphilic Star-Hyperbranched Block Copolymers for Drug Delivery
A robust drug delivery
system based on nanosized amphiphilic star-hyperbranched
block copolymer, namely, poly(methyl methacrylate-<i>block</i>-poly(hydroxylethyl methacrylate) (PMMA-<i>b</i>-PHEMA)
is described. PMMA-<i>b</i>-PHEMA was prepared by sequential
visible light induced self-condensing vinyl polymerization (SCVP)
and conventional vinyl polymerization. All of the synthesis and characterization
details of the conjugates are reported. To accomplish tumor cell targeting
property, initially cell-targeting (arginylglycylaspactic acid; RGD)
and penetrating peptides (Cys-TAT) were binding to each other via
the well-known EDC/NHS chemistry. Then, the resulting peptide was
further incorporated to the surface of the amphiphilic hyperbranched
copolymer via a coupling reaction between the thiol (−SH) group
of the peptide and the hydroxyl group of copolymer by using <i>N</i>-(<i>p</i>-maleinimidophenyl) isocyanate as a
heterolinker. The drug release property and targeting effect of the
anticancer drug (doxorobucin; DOX) loaded nanostructures to two different
cell lines were evaluated in vitro. U87 and MCF-7 were chosen as integrin
α<sub>v</sub>β<sub>3</sub> receptor positive and negative
cells for the comparison of the targeting efficiency, respectively.
The data showed that drug-loaded copolymers exhibited enhanced cell
inhibition toward U87 cells in compared to MCF-7 cells because targeting
increased the cytotoxicity of drug-loaded copolymers against integrin
α<sub>v</sub>β<sub>3</sub> receptor expressing tumor cells
Disease-related autoantibody profile in patients with systemic sclerosis
<p><b>Background:</b> Autoantibodies (autoAbs) help in diagnosis and predicting clinical phenotypes in systemic sclerosis (SSc).</p> <p><b>Aim of the study:</b> To determine the clinical utility of 13 SSc-related autoAbs in SSc patients.</p> <p><b>Material and methods:</b> A total of 131 consecutive patients with SSc (111 female, mean age 58.1 ± 14 years; 49 with diffused cutaneous SSc [dcSSc] and 82 with limited cutaneous SSc [lcSSc]) were analysed by a multiplex line immunoassay (Euroimmun) for autoantibodies (autoAbs) against 13 SSc-related antigens. A total of 22 patients with primary Raynaud phenomenon (RP), and 22 healthy controls were also analysed.</p> <p><b>Results:</b> ANA by indirect immunofluorescence was present in 128 (97.7%) patients with SSc. Excluding anti-Ro52, 113 (89.3%) SSc patients were positive for at least one autoAb: anti-Topoisomerase I (anti-Topo) I abs in 54 (41.2%), anti-centromere proteins (anti-CENP) in 37 (28.2%, all reactive with centromere protein-A (CENPA) and centromere protein B (CENPB)), anti-RNA polymerase III(RP11) in 19 (14.5%), anti-RNA polymerase III(RP155) in 13 (9.9%), anti-fibrillarin in 4 (3.1%), anti-Ku in 6 (4.6%), anti-nucleolus-organizing region (anti-NOR90) in 8 (6.1%), anti-PM-Scl100 in 2 (1.5%), and anti-PM-Scl75 in 4 (3.1%). There was no immunoreactivity for Th/To or platelet-derived growth factor receptor (PDGFR). Overall, 102 (77.9%) SSc patients had autoAbs against Topo I, CENPA or CENPB, RP11 or RP155. Anti-Topo I abs were strongly associated with dcSSc, interstitial lung disease (ILD) (<i>p</i> < .001), pulmonary hypertension (PH) (<i>p</i> = .019) and ILD-PH (<i>p</i> = .003). Anti-CENPB abs were associated with lcSSc, and negatively associated with ILD. Anti-RP11 and anti-NOR90 abs were associated with male gender, and anti-NOR90 associated with ILD.</p> <p><b>Conclusions:</b> Anti-Topo I, anti-CENP, and anti-RNA pol III are the most prevalent autoAbs in SSc. Anti-Topo I and anti-NOR90 abs are associated with ILD and/or PAH.</p
Identification of the Target Binding Site of Ethanolamine-Binding Aptamers and Its Exploitation for Ethanolamine Detection
Aptamers are promising recognition
elements for sensitive and specific
detection of small molecules. We have previously selected ssDNA aptamers
for ethanolamine, one of the smallest aptamer targets so far. The
work presented here focuses on the determination of the binding region
within the aptamer structure and its exploitation for the development
of an aptamer-based assay for detection of ethanolamine. Sequence
analysis of the aptamers resulted in the identification of a G-rich
consensus sequence, which was able to fold in a typical two- or three-layered
G-quartet structure. Experiments with stepwise truncated variants
of the aptamers revealed that the consensus sequence is responsible
and sufficient for binding to the target. On the basis of the knowledge
of the aptamers binding site, we developed an aptamer-based microarray
assay relying on competition between ethanolamine and an oligonucleotide
complementary to the consensus sequence. Competitive binding of ethanolamine
and fluorescently labeled complementary oligonucleotides resulted
in fluorescence intensities dependent on ethanolamine concentration
with a limit of detection of 10 pM. This method enables detection
of small molecules without any labeling of analytes. The competitive
assay could potentially be transferred to other aptamers and thus
provides a promising system for aptamer-based detection of diverse
small molecules
From Invisible Structures of SWCNTs toward Fluorescent and Targeting Architectures for Cell Imaging
Single-walled
carbon nanotubes (SWNTs) are unique nanostructures
used as cargo systems for variety of diagnostic and therapeutic agents.
For taking advantage of these structures in biological processes,
they should be visible. Therefore, fluorescence labeling of SWCNTs
with various probes is a significant issue. Herein, we demonstrate
a simple approach for cell specific imaging and diagnosis by combining
SWCNTs with a copolymer poly(<i>para</i>-phenylene) (PPP)
containing polystyrene (PSt) and poly(ε-caprolactone) (PCL)
side chains (PPP-<i>g</i>-PSt-PCL). In this approach PPP-<i>g-</i>PSt-PCL is noncovalently attached on carboxyl functional
SWCNTs. The obtained fluorescent probe is bound to folic acid (FA)
for targeted imaging of folate receptor (FR) positive HeLa cells.
In vitro studies demonstrate that this conjugate can specifically
bind to HeLa cells and indicate great potential for targeting and
imaging studies
Supplemental material for Comparison of different three dimensional-printed resorbable materials: <i>In vitro</i> biocompatibility, <i>In vitro</i> degradation rate, and cell differentiation support
<p>Supplemental material for Comparison of different three dimensional-printed resorbable materials: <i>In vitro</i> biocompatibility, <i>In vitro</i> degradation rate, and cell differentiation support by Lukas Raddatz, Marline Kirsch, Dominik Geier, Jörn Schaeske, Kevin Acreman, Rafael Gentsch, Scott Jones, Andreas Karau, Tommy Washington, Meike Stiesch, Thomas Becker, Sascha Beutel, Thomas Scheper and Antonina Lavrentieva in Journal of Biomaterials Applications</p